市场调查报告书
商品编码
1399739
脉搏血氧计市场规模(按产品类型、技术、年龄层、最终用途和预测),2022 年至 2030 年Pulse Oximeter Market Size By Product Type, By Technology, By Age Group, End-use & Forecast, 2022 - 2030 |
由于人们对呼吸健康监测的认识不断提高,预计 2023 年至 2032 年脉搏血氧计市场规模的CAGR将超过 6.5%。该设备测量血液中的氧饱和度。易用性和非侵入性使医疗保健专业人员和个人都可以使用它们进行远端监控。
此外,慢性呼吸道疾病(例如慢性阻塞性肺病(COPD)和气喘)的流行也大大促进了产品的更广泛采用。例如,全球气喘网路编写的《2022 年全球气喘报告》显示,印度约有 3,500 万人患有气喘。这些情况需要持续监测氧气水平,脉搏血氧仪提供了一种方便、即时的方法来评估呼吸状态。
全球脉搏血氧仪产业根据产品类型、技术、年龄层、最终用途和地区进行分类。
传统技术领域预计到 2032 年将大幅成长,这得益于其可靠性和在各种医疗保健环境中的广泛接受。儘管新技术不断涌现,但使用既定的光吸收原理的传统脉搏血氧仪仍然是测量血液中氧饱和度水平的值得信赖且经济高效的方法。其简单性和准确性使其成为首选,尤其是在难以获得复杂替代方案的偏远地区。
预计到 2032 年,家庭护理领域将为市场带来高收入,这归因于该设备能够方便、主动地监测个人健康状况。脉搏血氧仪已成为家庭使用的必备设备,特别是对于管理慢性呼吸系统疾病或监测整体健康状况的人。脉搏血氧计的用户友好性,加上便携式和以用户为中心的设计的进步,将促进其在家庭护理环境中的采用。
欧洲脉搏血氧仪产业份额将在 2023 年至 2032 年间显着增长,受到更容易患呼吸系统疾病的老龄化人口的青睐。完善的医疗基础设施,加上积极主动的预防保健方法,为这些设备的采用创造了有利的环境。此外,严格的监管标准和对以患者为中心的医疗保健实践的重视也有助于区域市场的成长。
Pulse Oximeter Market size is predicted to observe more than 6.5% CAGR from 2023 to 2032, driven by the rising awareness about respiratory health monitoring. The device measures oxygen saturation levels in the blood. The ease of use and non-invasive nature makes them accessible for both healthcare professionals and individuals for remote monitoring.
Additionally, the prevalence of chronic respiratory diseases, such as chronic obstructive pulmonary disease (COPD) and asthma, has significantly contributed to the wider product adoption. For instance, The Global Asthma Report 2022, prepared by Global Asthma Network, revealed that approximately 35 million people suffered from asthma in India. These conditions need continuous monitoring of oxygen levels, and pulse oximeters provide a convenient and immediate way to assess respiratory status.
The global pulse oximeter industry is classified on the basis of product type, technology, age group, end-use, and region.
The conventional technology segment is anticipated to witness substantial growth through 2032, favored by its reliability and widespread acceptance in various healthcare settings. While newer technologies continue to emerge, the conventional pulse oximeter, using established principles of light absorption, remains a trusted and cost-effective method for measuring oxygen saturation levels in the blood. Its simplicity and accuracy make it a preferred choice, especially in remote areas where sophisticated alternatives are less accessible.
Homecare segment is estimated to generate high revenues for the market by 2032, attributed to the device's ability to monitor individuals' health conveniently and proactively. Pulse oximeters have become essential devices for at-home use, particularly for those managing chronic respiratory conditions or monitoring overall wellness. The user-friendly nature of pulse oximeters, coupled with advancements in portable and user-centric designs will bolster its adoption in homecare settings.
Europe pulse oximeter industry share will grow significantly between 2023 and 2032, favored by aging population who are more prone to respiratory conditions. Well-established healthcare infrastructure, coupled with a proactive approach to preventive care, fosters a conducive environment for the adoption of these devices. Moreover, stringent regulatory standards and the emphasis on patient-centric healthcare practices contribute to the regional market growth.